Integrins in cancer: biological implications and therapeutic opportunities
Тип публикации: Journal Article
Дата публикации: 2010-01-01
SCImago Q1
Tоп 10% SCImago
WOS Q1
БС1
SJR: 22.814
CiteScore: 103.8
Impact factor: 66.8
ISSN: 1474175X, 14741768
PubMed ID:
20029421
General Environmental Science
General Earth and Planetary Sciences
Краткое описание
The integrins regulate a diverse array of cellular functions that are crucial to the initiation, progression and metastasis of solid tumours. This Review discusses the exciting developments in targeting integrins, including the recent initiation of a Phase III trial for an integrin antagonist in patients with glioblastoma. The integrin family of cell adhesion receptors regulates a diverse array of cellular functions crucial to the initiation, progression and metastasis of solid tumours. The importance of integrins in several cell types that affect tumour progression has made them an appealing target for cancer therapy. Integrin antagonists, including the αvβ3 and αvβ5 inhibitor cilengitide, have shown encouraging activity in Phase II clinical trials and cilengitide is currently being tested in a Phase III trial in patients with glioblastoma. These exciting clinical developments emphasize the need to identify how integrin antagonists influence the tumour and its microenvironment.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.
Топ-30
Журналы
|
10
20
30
40
50
60
70
80
|
|
|
Cancers
79 публикаций, 2.56%
|
|
|
Oncotarget
66 публикаций, 2.14%
|
|
|
Scientific Reports
55 публикаций, 1.78%
|
|
|
International Journal of Molecular Sciences
54 публикации, 1.75%
|
|
|
PLoS ONE
49 публикаций, 1.59%
|
|
|
Frontiers in Oncology
43 публикации, 1.39%
|
|
|
bioRxiv
42 публикации, 1.36%
|
|
|
Oncogene
35 публикаций, 1.13%
|
|
|
Journal of Controlled Release
32 публикации, 1.04%
|
|
|
Cancer Research
32 публикации, 1.04%
|
|
|
Pharmaceutics
25 публикаций, 0.81%
|
|
|
Cancer Letters
24 публикации, 0.78%
|
|
|
Advanced Drug Delivery Reviews
23 публикации, 0.74%
|
|
|
Bioconjugate Chemistry
23 публикации, 0.74%
|
|
|
Biomaterials
22 публикации, 0.71%
|
|
|
Molecular Pharmaceutics
22 публикации, 0.71%
|
|
|
Frontiers in Cell and Developmental Biology
21 публикация, 0.68%
|
|
|
Nature Communications
21 публикация, 0.68%
|
|
|
Journal of Biological Chemistry
19 публикаций, 0.61%
|
|
|
Cells
18 публикаций, 0.58%
|
|
|
Angewandte Chemie - International Edition
18 публикаций, 0.58%
|
|
|
Angewandte Chemie
18 публикаций, 0.58%
|
|
|
Journal of Medicinal Chemistry
16 публикаций, 0.52%
|
|
|
Biochemical and Biophysical Research Communications
16 публикаций, 0.52%
|
|
|
Experimental Cell Research
16 публикаций, 0.52%
|
|
|
Molecular Cancer Therapeutics
16 публикаций, 0.52%
|
|
|
Journal of Cell Science
15 публикаций, 0.49%
|
|
|
International Journal of Cancer
15 публикаций, 0.49%
|
|
|
ACS Nano
15 публикаций, 0.49%
|
|
|
10
20
30
40
50
60
70
80
|
Издатели
|
100
200
300
400
500
600
700
|
|
|
Elsevier
649 публикаций, 21%
|
|
|
Springer Nature
563 публикации, 18.22%
|
|
|
Wiley
318 публикаций, 10.29%
|
|
|
MDPI
271 публикация, 8.77%
|
|
|
American Chemical Society (ACS)
170 публикаций, 5.5%
|
|
|
Frontiers Media S.A.
116 публикаций, 3.75%
|
|
|
Taylor & Francis
99 публикаций, 3.2%
|
|
|
Royal Society of Chemistry (RSC)
92 публикации, 2.98%
|
|
|
Impact Journals
69 публикаций, 2.23%
|
|
|
American Association for Cancer Research (AACR)
69 публикаций, 2.23%
|
|
|
Public Library of Science (PLoS)
53 публикации, 1.72%
|
|
|
openRxiv
43 публикации, 1.39%
|
|
|
Spandidos Publications
40 публикаций, 1.29%
|
|
|
Hindawi Limited
36 публикаций, 1.17%
|
|
|
Oxford University Press
33 публикации, 1.07%
|
|
|
SAGE
28 публикаций, 0.91%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
24 публикации, 0.78%
|
|
|
American Society for Biochemistry and Molecular Biology
21 публикация, 0.68%
|
|
|
Bentham Science Publishers Ltd.
20 публикаций, 0.65%
|
|
|
The Company of Biologists
20 публикаций, 0.65%
|
|
|
Mary Ann Liebert
17 публикаций, 0.55%
|
|
|
American Association for the Advancement of Science (AAAS)
16 публикаций, 0.52%
|
|
|
American Society for Clinical Investigation
13 публикаций, 0.42%
|
|
|
Rockefeller University Press
12 публикаций, 0.39%
|
|
|
Society of Nuclear Medicine
11 публикаций, 0.36%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
11 публикаций, 0.36%
|
|
|
De Gruyter Brill
9 публикаций, 0.29%
|
|
|
American Physiological Society
9 публикаций, 0.29%
|
|
|
Bioscientifica
8 публикаций, 0.26%
|
|
|
100
200
300
400
500
600
700
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Войти с ORCID
Метрики
3.1k
Всего цитирований:
3092
Цитирований c 2025:
218
(7.05%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Desgrosellier J. S., Cheresh D. A. Integrins in cancer: biological implications and therapeutic opportunities // Nature Reviews Cancer. 2010. Vol. 10. No. 1. pp. 9-22.
ГОСТ со всеми авторами (до 50)
Скопировать
Desgrosellier J. S., Cheresh D. A. Integrins in cancer: biological implications and therapeutic opportunities // Nature Reviews Cancer. 2010. Vol. 10. No. 1. pp. 9-22.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1038/nrc2748
UR - https://doi.org/10.1038/nrc2748
TI - Integrins in cancer: biological implications and therapeutic opportunities
T2 - Nature Reviews Cancer
AU - Desgrosellier, Jay S
AU - Cheresh, David A
PY - 2010
DA - 2010/01/01
PB - Springer Nature
SP - 9-22
IS - 1
VL - 10
PMID - 20029421
SN - 1474-175X
SN - 1474-1768
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2010_Desgrosellier,
author = {Jay S Desgrosellier and David A Cheresh},
title = {Integrins in cancer: biological implications and therapeutic opportunities},
journal = {Nature Reviews Cancer},
year = {2010},
volume = {10},
publisher = {Springer Nature},
month = {jan},
url = {https://doi.org/10.1038/nrc2748},
number = {1},
pages = {9--22},
doi = {10.1038/nrc2748}
}
Цитировать
MLA
Скопировать
Desgrosellier, Jay S., and David A Cheresh. “Integrins in cancer: biological implications and therapeutic opportunities.” Nature Reviews Cancer, vol. 10, no. 1, Jan. 2010, pp. 9-22. https://doi.org/10.1038/nrc2748.
Ошибка в публикации?